FST and type 2 diabetes mellitus: Increased plasma follistatin levels in T2DM patients (Hansen et al., 2013; Sylow et al., 2020)Higher hepatic follistatin expression in MASLD patients (Tong et al., 2022)Moderate increase in plasma follistatin levels in obese patients (Maïmoun et al., 2020)